Schizophrenia and bipolar disorder. Treatment of cognitive impairments

被引:0
|
作者
Riedel, P. [1 ]
Smolka, M. N. [1 ]
Bauer, M. [1 ]
机构
[1] Univ Klinikum Carl Gustav Carus, Klin & Poliklin Psychiat & Psychotherapie, Fetscherstr 74, D-01307 Dresden, Germany
来源
NERVENARZT | 2018年 / 89卷 / 07期
关键词
Social cognition; Neurocognition; Non-pharmacological interventions; Pharmacotherapy; Functional capacity; DIRECT-CURRENT STIMULATION; INTERACTION TRAINING SCIT; SOCIAL COGNITION; CONTROLLED-TRIAL; 1ST-EPISODE SCHIZOPHRENIA; ANTIPSYCHOTIC MEDICATIONS; ANTICHOLINERGIC BURDEN; FUNCTIONAL REMEDIATION; SPECTRUM DISORDERS; AEROBIC EXERCISE;
D O I
10.1007/s00115-018-0500-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
More than half of the patients diagnosed with schizophrenia and a subgroup of patients diagnosed with bipolar disorder show impairment in neurocognitive and social cognitive performance. The degree of impairment varies from person to person. An improvement of cognitive impairment results in increased subjective quality of life and increased psychosocial functioning, to a much greater extent than successful treatment of other symptoms. Therefore, it is reasonable to not only recognize and bear decreased cognitive functioning in mind but also to offer specific treatment of impairments. The systematic review article in hand provides an overview of practice relevant treatment options in this respect. At present, cognitive remediation therapy shows the best treatment results, although only with moderate effect sizes. Physical activity can also be considered beneficial, even with the smaller number of studies available. Specific psychopharmacotherapy and non-invasive neurostimulation are still being assessed in clinical trials but show a promising perspective. Even though there are various beneficial treatment options to improve cognitive impairment potentially apparent in schizophrenia and bipolar disorder, future research will hopefully bring about even more effective interventions.
引用
收藏
页码:784 / 795
页数:12
相关论文
共 50 条
  • [1] Facial Emotion Recognition Impairments in Bipolar Disorder. A Cognitive Problem?
    Van Rheenen, Tamsyn
    Rossell, Susan
    [J]. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2016, 22 (06) : 583 - 585
  • [2] Cognitive impairments in bipolar disorder
    Sparding, T.
    Silander, K.
    Palsson, E.
    Ostlind, J.
    Sellgren, C.
    Ekman, C. J.
    Joas, E.
    Hansen, S.
    Landen, M.
    [J]. BIPOLAR DISORDERS, 2017, 19 : 39 - 40
  • [3] Role of rTMS in the treatment of cognitive impairments in Bipolar Disorder and Schizophrenia: a review of Randomized Controlled Trials
    Sciortino, Domenico
    Pigoni, Alessandro
    Delvecchio, Giuseppe
    Maggioni, Eleonora
    Schiena, Giandomenico
    Brambilla, Paolo
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2021, 280 : 148 - 155
  • [4] Guidelines for treatment of bipolar disorder.
    Dennehy E.B.
    [J]. Current Psychiatry Reports, 2000, 2 (4) : 316 - 321
  • [5] Neurotensin and its receptor in schizophrenia and bipolar disorder.
    Austin, J
    Hoogendoorn, B
    Buckland, P
    Middle, F
    Williams, N
    Craddock, N
    McGuffin, P
    Owen, MJ
    O'Donovan, MC
    [J]. MOLECULAR PSYCHIATRY, 1999, 4 : S102 - S103
  • [6] Overview of genome scans on schizophrenia and bipolar disorder.
    Crow, TJ
    DeLisi, LE
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1998, 81 (06): : 461 - 461
  • [7] DIFFERENTIAL HEDONIC CAPACITY IN SCHIZOPHRENIA AND BIPOLAR DISORDER.
    Grove, Tyler Barrett
    Tso, I. F.
    Taylor, S. F.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 20 - 20
  • [8] Schizophrenia and Bipolar Disorder In Terms of Cognitive Impairments; Similarities and Differences - A Systematic Review
    Cakir, Sibel
    Ucok, Alp
    [J]. NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2010, 47 (02): : 150 - 157
  • [9] Cognitive-behavioral therapy for bipolar disorder.
    Davidson, J
    [J]. BULLETIN OF THE MENNINGER CLINIC, 2000, 64 (04) : 558 - 558
  • [10] Cognitive impairments in patients with depressive disorder and bipolar disorder
    Kim, H. C.
    Kim, M. K.
    Lee, E. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S323 - S323